European Journal of Medicinal Chemistry p. 359 - 371 (2018)
Update date:2022-08-05
Topics: In vitro in vivo Metal Chelation Thiosemicarbazones Sigma-2 (σ2) receptor P-gp protein cytotoxic action
Pati, Maria Laura
Niso, Mauro
Spitzer, Dirk
Berardi, Francesco
Contino, Marialessandra
Riganti, Chiara
Hawkins, William G.
Abate, Carmen
The aggressiveness of pancreatic cancer urgently requires more efficient treatment options. Because the sigma-2 (σ2) receptor was recently proposed as a promising target for pancreatic cancer therapy, we explored our previously developed multifunctional thiosemicarbazones, designed to synergistically impair cell energy levels, by targeting σ2 and P-gp proteins and chelating Iron. A deconstruction approach was herein applied by removing one function at a time from the potent multifunctional thiosemicarbazones 1 and 2, to investigate the contribution to cytotoxicity of each target involved. The results from in vitro (panel of pancreatic tumor cells) and in vivo experiments (C57BL/6 bearing KP02 tumor), suggest that while the multifunctional activity was not required for the antitumor activity of these thiosemicarbazones, σ2-targeting appeared to allow alternative tumor cell death mechanisms, leading to potent and less toxic off-targets toxicities compared to other thiosemicarbazones devoid of σ2-targeting.
View MoreHangzhou Yingshanhua Pigment Chemicals Co.,Ltd.
Contact:+86-0150-58101658
Address:Nanyang Economic DevelopmentZong,Xiaoshan,Hangzhou,China
Beijing Hope Pharmaceutical Co., Ltd.
Contact:86-10-67886402
Address:309,Block 1 District B,No.12 Hongda North Road , Beijing Economic-Technological Development Area, Beijing, China
Contact:+86-25-83719363
Address:106-7 Chunnan Rd, Chunxi Town, Gaochun, Nanjing, China
Shanghai Dianyang Industry Co.,ltd
Contact:+86 21 6492 4669
Address:Chejing RD, Songjiang District, Shanghai, China
Yueyang Hudex Pharmaceuticals Ltd.
Contact:0730-8748800
Address:Wujiang Bridge,Yueyang Economy & Technology Development Zone
Doi:10.1002/hlca.19800630408
(1980)Doi:10.1002/hlca.19490320122
(1949)Doi:10.1021/jo00333a003
(1981)Doi:10.1139/v87-448
(1987)Doi:10.1016/S0960-894X(01)00499-1
(2001)Doi:10.1007/BF00503479
(1981)